ArticleHuman vaccines & immunotherapeutics2025
A cross-sectional study of the predictors of COVID-19 vaccine hesitancy in Pakistan.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transition from Free to Paid Vaccination: Willingness to Pay for COVID-19 Booster Doses in Vietnam in the Post-Pandemic Era.ClinicoEconomics and outcomes research : CEOR · 2026Article
- Underreporting of Adverse Events Following COVID-19 Vaccination Among Healthcare Professionals in Poland: Potential Implications for Vaccine Hesitancy.Tropical medicine and infectious disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vaccine hesitancy, where individuals are reluctant to get vaccinated, is a significant issue, especially in the event of a pandemic, and poses a major concern. We explore a few predictors of vaccine hesitancy in Pakistan using a cross-sectional study. For this purpose, 562 respondents registered their responses through an online questionnaire from March 31, 2021, to May 28, 2021, during the third wave of the COVID-19 pandemic. Cronbach's Alpha was used for Internal Consistency Reliability, while Factor Analysis was used for Construct Validity. We applied bivariate linear regression analysis for hypothesis testing. Fear of COVID-19 was higher among respondents as they suffered nervousness, fear of morbidity and mortality, and uncomfortable thinking about COVID-19. In vaccine hesitancy, two-fifths were unsure about, and concerned about the effectiveness of vaccines for new diseases, and the potential for serious side effects. More than half were exposed to negative information about COVID-19 vaccinations. One-third agreed that natural immunity against COVID-19 was a better option than vaccination. More than half perceived that vaccines could protect people from serious COVID-19 diseases and effectively control the spread of the virus, but they were unsure about new vaccines carrying more risks. Bivariate linear regression analysis revealed that younger age, lower knowledge about COVID-19, not quarantining due to COVID-19 symptoms, lower perceived effectiveness of vaccines in reducing the risk of COVID-19, previous negative experiences with vaccination, lower fear of COVID-19, and lower level of trust in health institutions were associated with higher vaccine hesitancy in Pakistan. We recommend further studies that should expand the sociocultural base of predictors of COVID-19 vaccine hesitancy by employing a mixed-methods research approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.